Compare KRT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRT | VOR |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.1M | 755.7M |
| IPO Year | 2019 | 2021 |
| Metric | KRT | VOR |
|---|---|---|
| Price | $28.44 | $14.90 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $26.50 | ★ $45.33 |
| AVG Volume (30 Days) | 69.2K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | ★ 6.30% | N/A |
| EPS Growth | ★ 4.70 | N/A |
| EPS | ★ 1.56 | N/A |
| Revenue | ★ $467,743,000.00 | N/A |
| Revenue This Year | $13.05 | N/A |
| Revenue Next Year | $8.11 | N/A |
| P/E Ratio | $18.29 | ★ N/A |
| Revenue Growth | ★ 10.67 | N/A |
| 52 Week Low | $20.61 | $0.13 |
| 52 Week High | $32.68 | $49.95 |
| Indicator | KRT | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 59.64 | 48.58 |
| Support Level | $27.11 | $11.38 |
| Resistance Level | $29.48 | $16.88 |
| Average True Range (ATR) | 0.76 | 1.57 |
| MACD | -0.06 | -0.08 |
| Stochastic Oscillator | 60.32 | 21.45 |
Karat Packaging Inc is engaged in the manufacturing and distribution of disposable products used in restaurants and food service settings. The company operates and evaluates its business as a single reportable segment which encompasses the manufacturing and distribution of a diverse range of single-use food and beverage service products made from materials such as plastic, paper, biopolymer-based, and other compostable forms. The company offers products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery, and straws. These products are available in plastic, paper, biopolymer-based and other compostable forms. Its product line includes a variety of brands such as Tea Zone, Karat, Karat Earth, and Total Clean.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.